Chabrier P E
Institut Henri Beaufour, Les Ulis, France.
Baillieres Clin Haematol. 1993 Sep;6(3):577-91. doi: 10.1016/s0950-3536(05)80189-1.
Endothelins (ETs) are a family of vasoactive peptides occurring in three isoforms (ET-1, ET-2, ET-3) encoded by three distinct genes in the human genome. ETs arise from precursor peptides (big-ETs) that are cleaved and released by an endothelin-converting enzyme. ET-1 secretion, which can be stimulated by various agents, is preferentially directed towards the abluminal site of endothelial cells, suggesting a local paracrine action of the peptide. ETs exert their actions through the activation of at least two receptor subtypes: ET-A receptors, which mediate the proliferative and vasoconstrictive effects, and ET-B receptors, which mediate vasorelaxation. Although, the potential roles of ETs are mostly hypothetical, considering their potent cardiovascular effects, it has been suggested that maintenance of a basal vascular tone and regulation of vascular growth and haemostasis may well represent the biological functions of this family of peptides. The recent discovery of specific receptor antagonists will provide a means to assess their physiological and pathophysiological roles.
内皮素(ETs)是一族血管活性肽,以三种异构体(ET-1、ET-2、ET-3)的形式存在,由人类基因组中三个不同的基因编码。内皮素由前体肽(大内皮素)产生,前体肽经内皮素转换酶裂解并释放。ET-1的分泌可受多种因素刺激,优先导向内皮细胞的管腔外位点,提示该肽具有局部旁分泌作用。内皮素通过激活至少两种受体亚型发挥作用:ET-A受体介导增殖和血管收缩作用,ET-B受体介导血管舒张。尽管考虑到内皮素强大的心血管效应,其潜在作用大多是假设性的,但有人提出维持基础血管张力以及调节血管生长和止血很可能代表了这一族肽的生物学功能。特异性受体拮抗剂的近期发现将为评估其生理和病理生理作用提供一种手段。